Real-time monitoring of oncolytic VSV properties in a novel in vitro microphysiological system containing 3D multicellular tumor spheroids.
As a new class of cancer therapeutic agents, oncolytic viruses (OVs) have gained much attention not only due to their ability to selectively replicate in and lyse tumor cells, but also for their potential to stimulate antitumor immune responses. As a result, there is an increasing need for in vitro...
Main Authors: | Kyoung Jin Lee, Sang Woo Lee, Ha-Na Woo, Hae Mi Cho, Dae Bong Yu, Soo Yeon Jeong, Chul Hyun Joo, Gi Seok Jeong, Heuiran Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0235356 |
Similar Items
-
The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma
by: Janine Kimpel, et al.
Published: (2018-03-01) -
Recent Advances in Multicellular Tumor Spheroid Generation for Drug Screening
by: Kwang-Ho Lee, et al.
Published: (2021-11-01) -
1410 Uncovering therapeutic vulnerabilities in gastric cancer with patient-specific microphysiological tumor spheroid systems
by: Jeeyun Lee, et al.
Published: (2023-11-01) -
Repurposing the oncolytic virus VSV∆51M as a COVID-19 vaccine
by: Almohanad A. Alkayyal, et al.
Published: (2023-07-01) -
Tunable hybrid hydrogels with multicellular spheroids for modeling desmoplastic pancreatic cancer
by: Menekse Ermis, et al.
Published: (2023-07-01)